Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1361 - 1368 of 11617 results
New York State Adopts Amendments to Pay Transparency Law
March 21, 2023| Blog| Viewpoint
It’s Going to be a Big Year for FINRA
March 21, 2023| Blog| Viewpoint
Outlook For The Global Venture Capital Market & The Need For Bipartisan Regulations
March 21, 2023| News
EPA Bid For ‘Durable’ WOTUS Rule Falters After Judge Raises Legal Doubts
March 21, 2023| News
Mintz Law Firm Goes North: Launches In Canada With New Toronto Office
March 21, 2023| News
FDA Modernizes Mammography Regulations, Provides Facilities with Eighteen-Month Compliance Deadline
March 20, 2023| Blog| Viewpoint
Biden Uses Veto To Preserve DOL Rule On ESG Investing
March 20, 2023| News
Clean Water Act Under Fire Again: The Legal Landscape Of WOTUS
March 20, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.